Literature DB >> 12654840

Rapid protection of gnotobiotic pigs against experimental salmonellosis following induction of polymorphonuclear leukocytes by avirulent Salmonella enterica.

N Foster1, M A Lovell, K L Marston, S D Hulme, A J Frost, P Bland, P A Barrow.   

Abstract

Oral inoculation of 5-day-old gnotobiotic pigs with Salmonella enterica serovar Typhimurium strain F98 resulted in severe enteritis and invasive disease. Preinoculation 24 h earlier with an avirulent mutant of Salmonella enterica serovar Infantis (1326/28) completely prevented disease for up to 14 days (when the experiment was terminated). S. enterica serovar Infantis colonized the alimentary tract well, with high bacterial counts in the intestinal lumen but with almost no invasion into the tissues. Unprotected pigs had high S. enterica serovar Typhimurium counts in the intestines, blood, and major nonintestinal organs. Recovery of this strain from the blood and major organs in S. enterica serovar Infantis-protected pigs was substantially reduced despite the fact that intestinal counts were also very high. Protection against disease thus did not involve a colonization exclusion phenomenon. Significant (P < 0.05) infiltration of monocytes/macrophages was observed in the submucosal regions of the intestines of both S. enterica serovar Infantis-protected S. enterica serovar Typhimurium-challenged pigs and unprotected S. enterica serovar Typhimurium-challenged pigs. However, only polymorphonuclear neutrophils (PMNs) were observed throughout the villus, where significant (P < 0.05) numbers infiltrated the lamina propria and the subnuclear and supranuclear regions of the epithelia, indicating that PMN induction and positioning following S. enterica serovar Infantis inoculation was consistent with rapid protection against the challenge strain. Similarly, in vitro experiments using a human fetal intestinal epithelial cell line (INT 407) demonstrated that, although significantly (P < 0.05) fewer S. enterica serovar Infantis than S. enterica serovar Typhimurium organisms invaded the monolayers, S. enterica serovar Infantis induced an NF-kappaB response and significantly (P < 0.05) raised interleukin 8 levels and transmigration of porcine PMN. The results of this study suggest that attenuated Salmonella strains can protect the immature intestine against clinical salmonellosis by PMN induction. They also demonstrate that PMN induction is not necessarily associated with clinical symptoms and/or intestinal pathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654840      PMCID: PMC152035          DOI: 10.1128/IAI.71.4.2182-2191.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Neutrophil-derived proteins: selling cytokines by the pound.

Authors:  M A Cassatella
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

2.  Studies on the rapid production of a non-specific type of immunity to Salmonella typhi infection in mice.

Authors:  T E FIELD; J G HOWARD; J L WHITBY
Journal:  J R Army Med Corps       Date:  1955-10       Impact factor: 1.285

3.  The use of live vaccines in experimental Salmonella gallinarum infection in chickens with observations on their interference effect.

Authors:  H W SMITH
Journal:  J Hyg (Lond)       Date:  1956-09

4.  Cl- secretion in a model intestinal epithelium induced by a neutrophil-derived secretagogue.

Authors:  J L Madara; C Parkos; S Colgan; R J MacLeod; S Nash; J Matthews; C Delp; W Lencer
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Intestinal colonisation of gnotobiotic pigs by Salmonella organisms: interaction between isogenic and unrelated strains.

Authors:  M A Lovell; P A Barrow
Journal:  J Med Microbiol       Date:  1999-10       Impact factor: 2.472

6.  Migration of neutrophils through epithelial monolayers.

Authors:  J L Madara
Journal:  Trends Cell Biol       Date:  1994-01       Impact factor: 20.808

7.  IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation.

Authors:  Noriyuki Ohta; Takachika Hiroi; Mi-Na Kweon; Naotoshi Kinoshita; Myoung Ho Jang; Tadashi Mashimo; Jun-Ichi Miyazaki; Hiroshi Kiyono
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model.

Authors:  S Tzipori; J Montanaro; R M Robins-Browne; P Vial; R Gibson; M M Levine
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

9.  Early cytokine response of gnotobiotic piglets to Salmonella enterica serotype typhimurium.

Authors:  Igor Splíchal; Ilja Trebichavský; Yoshihiro Muneta; Yasuyuki Mori
Journal:  Vet Res       Date:  2002 May-Jun       Impact factor: 3.683

10.  Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways.

Authors:  C A Parkos; S P Colgan; C Delp; M A Arnaout; J L Madara
Journal:  J Cell Biol       Date:  1992-05       Impact factor: 10.539

View more
  16 in total

1.  Alarmin HMGB1 is released in the small intestine of gnotobiotic piglets infected with enteric pathogens and its level in plasma reflects severity of sepsis.

Authors:  Alla Splichalova; Igor Splichal; Petra Chmelarova; Ilja Trebichavsky
Journal:  J Clin Immunol       Date:  2011-01-12       Impact factor: 8.317

2.  Stimulation of gp91 phagocytic oxidase and reactive oxygen species in neutrophils by an avirulent Salmonella enterica serovar infantis strain protects gnotobiotic piglets from lethal challenge with serovar Typhimurium strain F98 without inducing intestinal pathology.

Authors:  Neil Foster; Scott Hulme; Margaret Lovell; Katharine Reed; Paul Barrow
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Campylobacter jejuni-induced cytokine responses in avian cells.

Authors:  Chris K Smith; Pete Kaiser; Lisa Rothwell; Tom Humphrey; Paul A Barrow; Michael A Jones
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine.

Authors:  A Splichalova; I Trebichavsky; V Rada; E Vlkova; U Sonnenborn; I Splichal
Journal:  Clin Exp Immunol       Date:  2010-12-13       Impact factor: 4.330

5.  Chicken-Specific Kinome Analysis of Early Host Immune Signaling Pathways in the Cecum of Newly Hatched Chickens Infected With Salmonella enterica Serovar Enteritidis.

Authors:  Michael H Kogut; Kenneth J Genovese; J Allen Byrd; Christina L Swaggerty; Haiqi He; Yuhua Farnell; Ryan J Arsenault
Journal:  Front Cell Infect Microbiol       Date:  2022-06-30       Impact factor: 6.073

6.  6-hydroxydopamine-mediated release of norepinephrine increases faecal excretion of Salmonella enterica serovar Typhimurium in pigs.

Authors:  Gillian D Pullinger; Pauline M van Diemen; Sonya C Carnell; Holly Davies; Mark Lyte; Mark P Stevens
Journal:  Vet Res       Date:  2010-07-09       Impact factor: 3.683

7.  A pig model of the human gastrointestinal tract.

Authors:  Quanshun Zhang; Giovanni Widmer; Saul Tzipori
Journal:  Gut Microbes       Date:  2013-04-02

Review 8.  Immunometabolic Phenotype Alterations Associated with the Induction of Disease Tolerance and Persistent Asymptomatic Infection of Salmonella in the Chicken Intestine.

Authors:  Michael H Kogut; Ryan J Arsenault
Journal:  Front Immunol       Date:  2017-04-04       Impact factor: 7.561

Review 9.  Pre-existing immunity against vaccine vectors--friend or foe?

Authors:  Manvendra Saxena; Thi Thu Hao Van; Fiona J Baird; Peter J Coloe; Peter M Smooker
Journal:  Microbiology       Date:  2012-11-22       Impact factor: 2.777

Review 10.  Animal models to study acute and chronic intestinal inflammation in mammals.

Authors:  Janelle A Jiminez; Trina C Uwiera; G Douglas Inglis; Richard R E Uwiera
Journal:  Gut Pathog       Date:  2015-11-10       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.